Recipient NOD2/CARD15 variants:: A novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation

被引:43
作者
Hildebrandt, Gerhard C. [1 ]
Granell, Miguell [4 ]
Urbano-Lspizua, Alvaro [4 ]
Wolff, Daniel [5 ]
Hertenstein, Bernd [6 ]
Greinix, Hildegard T. [7 ]
Brenmoehl, Julia [1 ]
Schulz, Christian [2 ]
Dickinson, Anne M. [8 ,9 ]
Hahn, Joachim [1 ]
Rogler, Gerhard [3 ]
Andreesen, Reinhard [1 ]
Holler, Ennst [1 ]
机构
[1] Univ Regensburg, Sch Med, Dept Hematol & Oncol, D-93053 Regensburg, Germany
[2] Univ Regensburg, Sch Med, Dept Pulmonol, D-93053 Regensburg, Germany
[3] Univ Regensburg, Sch Med, Dept Gastroenterol, D-93053 Regensburg, Germany
[4] Univ Barcelona, Fac Med, Dept Hematol, Barcelona 7, Spain
[5] Univ Rostock, Sch Med, Dept Hematol & Oncol, Rostock, Germany
[6] Hannover Med Sch, Dept Hematol, Hannover, Germany
[7] Vienna Med Univ, Dept Internal Med 1, Vienna, Austria
[8] Univ Newcastle, Sch Clin, Newcastle Upon Tyne, Tyne & Wear, England
[9] Univ Newcastle, Sci Labs, Newcastle Upon Tyne, Tyne & Wear, England
关键词
bronchiolitis obliterans; chronic GVHD; NOD2; stem cell transplantation;
D O I
10.1016/j.bbmt.2007.09.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bronchiolitis obliterans (BO) is a serious complication after allogeneic stem cell transplantation. We hypothesized that single nucleotide polymorphisms (SNPs) of the NOD2/CARD15 gene (= NOD2/CARD15 variants) contribute to changes in host defense and subsequent alloreaction, leading to BO. We analyzed 427 donor-recipient pairs for the association of NOD2/CARD15 variants (SNP8 [Arg702Trp], SNP12 [Gly908Arg], and SNP13 [Leu1007fsinsC]) with BO occurrence. Overall, 11 patients (2.6%) developed BO. The cumulative incidence of BO rose from 1.3 % in donor-recipient pairs without mutation to 18.7% in pairs with donor or recipient NOD2/CARD15 variants (P <.001). Recipient NOD2/CARD15 variants alone led to BO in 22.3% (P <.001), whereas donor variants alone associated with BO in 13.2% (P =.04). Multivariate analysis proved recipient but not donor NOD2/CARD15 variants to be a novel independent risk factor for BO development, and NOD2/CARD15 typing may help identify patients at increased risk for BO. (c) 2008 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 49 条
[1]   NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease [J].
Aldhous, MC ;
Nimmo, ER ;
Satsangi, J .
GUT, 2003, 52 (11) :1533-1535
[2]   Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15 [J].
Becker, Mara L. ;
Martin, Tammy M. ;
Doyle, Trudy M. ;
Rose, Carlos D. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1292-1294
[3]  
Beinert T, 1996, Eur J Med Res, V1, P343
[4]   Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon [J].
Berrebi, D ;
Maudinas, R ;
Hugot, JP ;
Chamaillard, M ;
Chareyre, F ;
De Lagausie, P ;
Yang, C ;
Desreumaux, P ;
Giovannini, M ;
Cézard, JP ;
Zouali, H ;
Emilie, D ;
Peuchmaur, M .
GUT, 2003, 52 (06) :840-846
[5]   IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract [J].
Burman, Angela C. ;
Banovic, Tatjana ;
Kuns, Rachel D. ;
Clouston, Andrew D. ;
Stanley, Amanda C. ;
Morris, Edward S. ;
Rowe, Vanessa ;
Bofinger, Helen ;
Skoczylas, Renae ;
Raffelt, Neil ;
Fahy, Olivier ;
McColl, Shaun R. ;
Engwerda, Christian R. ;
McDonald, Kelli P. A. ;
Hill, Geoffrey R. .
BLOOD, 2007, 110 (03) :1064-1072
[6]   Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation [J].
Chien, JW ;
Zhao, LP ;
Hansen, JA ;
Fan, WH ;
Parimon, T ;
Clark, JG .
BLOOD, 2006, 107 (05) :2200-2207
[7]   Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation [J].
Chien, JW ;
Martin, PJ ;
Gooley, TA ;
Flowers, ME ;
Heckbert, SR ;
Nichols, WG ;
Clark, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) :208-214
[8]   OBSTRUCTIVE LUNG-DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION - CLINICAL PRESENTATION AND COURSE [J].
CLARK, JG ;
CRAWFORD, SW ;
MADTES, DK ;
SULLIVAN, KM .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (05) :368-376
[9]   RISK-FACTORS FOR AIR-FLOW OBSTRUCTION IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J].
CLARK, JG ;
SCHWARTZ, DA ;
FLOURNOY, N ;
SULLIVAN, KM ;
CRAWFORD, SW ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :648-656
[10]   Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD) [J].
Dosanjh, A ;
Wan, B ;
Ikonen, T ;
Boeke, K ;
Morris, RE .
AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (04) :321-324